{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-25-005597","form_type":"8-K","ticker":null,"cik":"0001331612","company_name":"AnTix Holdings, Inc.","filed_at":"2025-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.727304+00:00","generated_at":"2026-05-17T16:12:11.424500+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Innovative MedTech sells $97,750 convertible note to Labrys Fund, netting $77K","bullets":["Sold $97,750 convertible promissory note to Labrys Fund II, L.P. for $85,000; net funding $77,000 after legal and placement agent fees.","Note matures in 12 months, accrues 12% fixed interest, convertible at 71% of lowest closing bid price over prior 10 trading days.","Conversion capped at 4.99% beneficial ownership (9.99% after 61 days with notice); holder deducts $1,500 per conversion for fees.","Proceeds earmarked for business development and general working capital; not for insider debt repayment or loans.","Issued under Section 4(a)(2) exemption from registration; includes customary representations, warranties, and closing conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-25-005597","json":"https://secwatch.observer/filing/0001477932-25-005597.json","markdown":"https://secwatch.observer/filing/0001477932-25-005597.md","text":"https://secwatch.observer/filing/0001477932-25-005597.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1331612/000147793225005597/0001477932-25-005597-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1331612/000147793225005597/imth_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T16:12:11.424500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dafaf70defcd6a9c9f6f245ff3325566bd321f69","claim":"AnTix Holdings, Inc. incurred convertible notes of $97,750 with Labrys Fund II, L.P. at a one-time interest charge of 12% on the principal amount at issuance maturing twelve months following the issue date.","evidence_excerpt":"Effective as of August 6, 2025, Innovative MedTech, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ SPA ”) with Labrys Fund II, L.P., a Delaware limited partnership (“ Labrys ”), pursuant to which the Company sold, and Labrys purchased, a convertible promissory note in the principal amount of $97,750 (the “ Note ”) for a purchase price of $85,000 (the “ Transaction ”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1331612/000147793225005597/0001477932-25-005597-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$97,750"},{"label":"Counterparty","value":"Labrys Fund II, L.P."},{"label":"Rate","value":"a one-time interest charge of 12% on the principal amount at issuance"},{"label":"Maturity","value":"twelve months following the issue date"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}